Small Molecule HMS LINCS ID,Small Molecule Name,Cell Line HMS LINCS ID,Cell Line Name,Protein HMS LINCS ID,Protein Name,Sequence,Labeling Site,% Inhibition,Assay compound conc,Conc unit
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200633,"ABL,ARG",LMTGDTYTAHAGAKFPIK,Activation Loop,-12.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200635,ACK,TVSVAVKCLKPDVLSQPEAMDDFIR,Lys1,-39.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200640,"AMPKa1,AMPKa2",VAVKILNR,Lys1,8.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200643,ATR,FYIMMCKPK,ATP,-76.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200644,AurA,DIKPENLLLGSAGELK,Lys2,14.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201072,AurB,SHFIVALKVLFK,Lys1,-6.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200877,BARK1,DLKPANILLDEHGHVR,Lys2,-1.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200647,BRAF,DLKSNNIFLHEDLTVK,Lys2,31.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200880,BTK,GQYDVAIKMIK,Lys1,>97,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200881,BTK,YVLDDEYTSSVGSKFPVR,Activation Loop,98.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200882,CAMK1D,LFAVKCIPK,Lys1,-20.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201047,"CaMK2a,CaMK2b,CaMK2d,CaMK2g",DLKPENLLLASK,Lys2,-8.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200654,CDC2,DLKPQNLLIDDKGTIK,Lys2,16.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200656,"CDK11,CDK8",DLKPANILVMGEGPER,Lys2,-51.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200658,CDK2,DLKPQNLLINTEGAIK,Lys2,-1.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200890,CDK5,DLKPQNLLINR,Lys2,-2.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200663,CDK7,DLKPNNLLLDENGVLK,Lys2,7.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200666,CHK2,VAIKIISK,Lys1,-1.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200667,KC1A,DIKPDNFLMGIGR,Lys2,-61.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200669,CSK,VSDFGLTKEASSTQDTGKLPVK,Activation Loop,25.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200674,DNAPK,EHPFLVKGGEDLR,ATP,-20.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200677,eEF2K,YIKYNSNSGFVR,ATP,-28.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200681,MK03,DLKPSNLLINTTCDLK,Lys2,-35.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200686,FER,TSVAVKTCKEDLPQELK,Lys1,-16.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200918,FGR,LIKDDEYNPCQGSKFPIK,Activation Loop,54.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200921,FRAP1,IQSIAPSLQVITSKQRPR,ATP,0.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200687,"FYN,SRC,YES",QGAKFPIKWTAPEAALYGR,Activation Loop,7.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200690,GCK,DIKGANLLLTLQGDVK,Lys2,-5.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200693,GSK3A,DIKPQNLLVDPDTAVLK,Lys2,0.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200694,GSK3B,DIKPQNLLLDPDTAVLK,Lys2,8.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200928,HPK1,DKVSGDLVALKMVK,Lys1,-39.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200933,IKKE,SGELVAVKVFNTTSYLRPR,Lys1,9.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200697,"IKKE,TBK1",DIKPGNIMR,Lys2,-66.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200698,ILK,ISMADVKFSFQCPGR,Protein Kinase Domain,-37.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200701,IRAK4,DIKSANILLDEAFTAK,Lys2,5.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200704,JAK1,QLASALSYLEDKDLVHGNVCTKNLLLAR,Protein Kinase Domain,-61.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200705,JAK1_domain2,YDPEGDNTGEQVAVKSLKPESGGNHIADLKK,Lys1,-24.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200707,"JNK1,JNK2,JNK3",DLKPSNIVVK,Lys2,-3.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200710,KHS1,NVHTGELAAVKIIK,Lys1,14.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200712,LKB1,DIKPGNLLLTTGGTLK,Lys2,-6.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200714,LOK,DLKAGNVLMTLEGDIR,Lys2,-60.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200940,LYN,VAVKTLKPGTMSVQAFLEEANLMK,Lys1,-50.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200941,LYN,EGAKFPIKWTAPEAINFGCFTIK,Activation Loop,-23.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200718,MAP2K1,IMHRDVKPSNILVNSR,Lys2,-41.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200719,"MAP2K1,MAP2K2",DVKPSNILVNSR,Lys2,-8.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200722,MAP2K3,DVKPSNVLINK,Lys2,7.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200724,MAP2K4,DIKPSNILLDR,Lys2,7.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200725,MAP2K5,DVKPSNMLVNTR,Lys2,31.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200726,MAP2K6,DVKPSNVLINALGQVK,Lys2,11.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200729,MP2K7,DVKPSNILLDER,Lys2,9.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200730,MAP3K1,DVKGANLLIDSTGQR,Lys2,28.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200732,"M3K2,MAP3K3",DIKGANILR,Lys2,21.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200734,MAP3K4,DIKGANIFLTSSGLIK,Lys2,22.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200944,MAP3K5,DIKGDNVLINTYSGVLK,Lys2,-9.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200739,"MARK2,MARK3",DLKAENLLLDADMNIK,Lys2,-28.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200740,MARK3,EVAIKIIDKTQLNPTSLQK,Lys1,12.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200743,MAST3,DLKPDNLLITSLGHIK,Lys2,-9.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200950,MASTL,LYAVKVVK,Lys1,9.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200751,MST1,ETGQIVAIKQVPVESDLQEIIK,Lys1,-0.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200755,MST2,ESGQVVAIKQVPVESDLQEIIK,Lys1,6.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200756,MST3,DIKAANVLLSEHGEVK,Lys2,12.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200759,"MST4,YSK1",DIKAANVLLSEQGDVK,Lys2,-8.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200760,NDR1,DTGHVYAMKILR,Lys1,-53.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200765,NDR2,DIKPDNLLLDAK,Lys2,8.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200960,NEK3,SKNIFLTQNGK,Activation Loop,-7.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200768,"NEK6,NEK7",DIKPANVFITATGVVK,Lys2,14.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200770,NEK7,AACLLDGVPVALKK,Lys1,-54.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200774,NEK9,DIKTLNIFLTK,Lys2,6.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200967,MK14,QELNKTIWEVPER,Protein Kinase Domain,-68.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200777,"p38d,p38g",DLKPGNLAVNEDCELK,Lys2,-36.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200779,KS6B1,DLKPENIMLNHQGHVK,Lys2,-47.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200787,CDK14,LVALKVIR,Lys1,21.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200790,PI4KB,VPHTQAVVLNSKDK,ATP,14.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200793,PIK3C3,TEDGGKYPVIFKHGDDLR,ATP,-7.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200976,PIK3CB,VFGEDSVGVIFKNGDDLR,ATP,8.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200977,PIK3CD,VNWLAHNVSKDNRQ,ATP,-50.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200797,PIP4K2A,AKELPTLKDNDFINEGQK,ATP,0.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200799,PI42C,TLVIKEVSSEDIADMHSNLSNYHQYIVK,ATP,-87.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200800,FYV1,GGKSGAAFYATEDDRFILK,ATP,-1.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200801,PITSLRE,DLKTSNLLLSHAGILK,Lys2,7.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200805,"PKD1,PKD2",NIVHCDLKPENVLLASADPFPQVK,Lys2,12.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201064,PKD2,DVAVKVIDK,Lys1,13.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200807,PKD3,NIVHCDLKPENVLLASAEPFPQVK,Lys2,-34.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201094,PKN1,VLLSEFRPSGELFAIKALK,Lys1,7.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200809,PKR,DLKPSNIFLVDTK,Lys2,4.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200810,PLK1,CFEISDADTKEVFAGKIVPK,Lys1,21.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200997,FAK2,YIEDEDYYKASVTR,Activation Loop,-12.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200814,"ROCK1,ROCK2",DVKPDNMLLDK,Lys2,-59.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201045,RSK1 domain1,DLKPENILLDEEGHIKLTDFGLSKEAIDHEK,Lys2,-36.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200819,RSK1_domain2,DLKPSNILYVDESGNPECLR,Lys2,-3.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200821,RSK2_domain2,DLKPSNILYVDESGNPESIR,Lys2,14.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200826,SGK3,FYAVKVLQK,Lys1,5.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200829,SLK,DLKAGNILFTLDGDIK,Lys2,-4.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200833,STLK5,YSVKVLPWLSPEVLQQNLQGYDAK,Activation Loop,-14.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201099,STLK6,SIKASHILISGDGLVTLSGLSHLHSLVK,Lys2,16.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201069,SYK,ISDFGLSKALR,Activation Loop,3.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201017,SYK,TVAVKILK,Lys1,12.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200834,"TAO1,TAOK3",DIKAGNILLTEPGQVK,Lys2,-15.4,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200835,TAOK2,DVKAGNILLSEPGLVK,Lys2,-19.1,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201077,TEC,YVLDDQYTSSSGAKFPVK,Activation Loop,>90,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200837,TLK1,YLNEIKPPIIHYDLKPGNILLVDGTACGEIK,Lys2,-41.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201022,TLK1/2,YLNEIKPPIIHYDLKPGNILLVNGTACGEIK,Lys2,-2.7,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201026,ULK3,EVVAIKCVAK,Lys1,-3.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200845,MLTK,WISQDKEVAVKK,Lys1,28.3,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),200847,"ZC1/HGK,ZC2/TNIK,ZC3/MINK",DIKGQNVLLTENAEVK,Lys2,-45.9,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201163,BLK,IIDSEYTAQEGAKFPIK,Activation Loop,>99,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201210,KCC2D,IPTGQEYAAKIINTKK,Lys1,24.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201208,KC1G1,DVKPENFLIGR,Lys2,-1.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201209,KC1G2,DVKPENFLVGRPGTK,Lys2,-17.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201217,LCK,EGAKFPIKWTAPEAINYGTFTIK,Activation Loop,-2.6,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201231,"MARK1,MARK2",EVAVKIIDK,Lys1,25.8,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201213,KPCI,DLKLDNVLLDSEGHIK,Lys2,19.2,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201282,ZAP70,ISDFGLSKALGADDSYYTAR,Activation Loop,10.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201167,KCC4,DLKPENLLYATPAPDAPLK,Lys2,-3.0,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201192,MK01,DLKPSNLLLNTTCDLK,Lys2,21.5,1,uM
10129-101-1,Ibrutinib,50811-1,Ramos (RA 1),201262,RSK2 domain1,DLKPENILLDEEGHIKLTDFGLSKESIDHEK,Lys2,-17.1,1,uM
